Analyst Ratings for Pacific Biosciences of California (pacb)

pacb Rating Summary

pacb Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pacb
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $7.00 (+37.5%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
5/1/2014 JPMorgan Upgrade Neutral
(Underweight)
7.00
(N/A)
4.42 5.09 15.16% Details
8/2/2013 Piper Jaffray Upgrade Neutral
(Underweight)
3.10
(2.00)
2.67 5.09 90.64% Details
Like PACB Ratings? Also take a look at RHHBY

PACB Ratings News